RA
Rosalind Advisors’s KalVista Pharmaceuticals KALV Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.78M | Sell |
157,725
-146,139
| -48% | -$1.65M | 0.85% | 23 |
|
|
2025
Q1 | $3.51M | Hold |
303,864
| – | – | 1.71% | 21 |
|
|
2024
Q4 | $2.57M | Hold |
303,864
| – | – | 1.32% | 21 |
|
|
2024
Q3 | $3.52M | Sell |
303,864
-34,121
| -10% | -$395K | 2.25% | 15 |
|
|
2024
Q2 | $3.98M | Buy |
337,985
+50,000
| +17% | +$589K | 3.06% | 15 |
|
|
2024
Q1 | $3.42M | Sell |
287,985
-12,015
| -4% | -$142K | 3.19% | 15 |
|
|
2023
Q4 | $3.68M | Buy |
+300,000
| New | +$3.68M | 3.03% | 16 |
|